Heavy metal contaminants pose a risk to health – the cannabis industry must react accordingly.
Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.
A dose-escalation study aims to quantify the value of CBD in children with epileptic encephalopathy.
Restrictive legislation won’t prevent efforts to progress cannabis research
Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly
Ill-considered regulations have resulted in an analytical race to the bottom.
Apples to oranges… to cannabis. Strain classifications in US dispensaries are not always what they appear.
From early-stage research to clinical practice, four experts offer their take on the potential of cannabis-based pain relief.
We delve deeper into the numbers to ask - what role can cannabis play in fighting the pain epidemic?
Microbial safety: why viability testing fails to protect patients.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.